Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Varex Imaging ( (VREX) ) has issued an update.
At Varex Imaging’s annual meeting held on February 12, 2026, shareholders representing about 92% of eligible common stock were present in person or by proxy, establishing a quorum for all items of business. Investors elected seven directors, including Kathleen L. Bardwell and Sunny S. Sanyal, to serve until the 2027 annual meeting, reinforcing continuity in the company’s board leadership and governance structure.
Shareholders also approved on an advisory basis the compensation of the company’s named executive officers, signaling broad support for Varex Imaging’s current pay practices and leadership incentives. In addition, investors ratified Deloitte & Touche LLP as the independent registered public accounting firm for fiscal 2026, maintaining the existing audit relationship and underpinning financial reporting stability for the coming year.
The most recent analyst rating on (VREX) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Varex Imaging stock, see the VREX Stock Forecast page.
Spark’s Take on VREX Stock
According to Spark, TipRanks’ AI Analyst, VREX is a Neutral.
The score is held back primarily by weakened financial performance (losses, negative ROE, and negative TTM free cash flow) despite strong revenue growth. Technicals are supportive with an uptrend and positive momentum, while valuation is constrained by negative earnings. The latest earnings call was moderately positive on guidance and demand signals but tempered by cash flow pressure, inventory build, and refinancing risk.
To see Spark’s full report on VREX stock, click here.
More about Varex Imaging
Varex Imaging is a medical imaging technology company that designs and manufactures X‑ray imaging components and solutions used by healthcare and industrial customers. Its products typically support diagnostic imaging systems and related applications, positioning the company as a key supplier within the global medical device and imaging equipment value chain.
Average Trading Volume: 362,501
Technical Sentiment Signal: Hold
Current Market Cap: $570.3M
For a thorough assessment of VREX stock, go to TipRanks’ Stock Analysis page.